Unique general anesthetic binding sites within distinct conformational states of the nicotinic acetylcholine receptor

International Review of Neurobiology

Volumn 54, Issue , 2003, Pages 1-24

  Arias, Hugo R ^a   Kem, William R ^b   Trudell, James R ^c   Blanton, Michael P ^d  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ION CHANNEL; NICOTINIC RECEPTOR; PROTEIN SUBUNIT; STEROID;

ANIMAL; BINDING SITE; CHEMISTRY; CONFORMATION; HUMAN; PHYSIOLOGY; REVIEW;

ANESTHETICS, GENERAL; ANIMALS; BINDING SITES; HUMANS; ION CHANNELS; MOLECULAR CONFORMATION; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC; STEROIDS;

EID: 0038209584     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(03)54002-8     Document Type: Review

References (223)

1. Aistrup, G. L., Marszalec, W., and Narahashi, T. (1999). Ethanol modulation of nicotinic acetylcholine receptor currents in cultured cortical neurons. Mol. Pharmacol. 55, 39-49.
2. Albuquerque, E. X., Alkondon, M., Pereira, E. F. R., Castro, N. G., Schrattenholz, A., Barbosa, C. T. F., Bonfante-Cabarcas, R., Aracava, Y., Eisenberg, H. M., and Maelicke, A. (1997). Properties of neuronal nicotinic acetylcholine receptors: Pharmacological characterization and modulation of synaptic function. J. Pharmacol. Exp. Ther. 280, 1117-1136.
3. Allen, M. C., Newland, C., Valverde, M. A., and Hardy, S. P. (1998). Inhibition of ligand-gated cation-selective channels by tamoxifen. Eur. J. Pharmacol. 354, 261-269.
4. Amador, M., and Dani, J. A. (1991). MK-801 inhibition of nicotinic acetylcholine receptor channels. Synapse 7, 207-215.
5. Anand, R., Conroy, W. G., Schoepfer, R., Whiting, P., and Lindstrom, J. (1991). Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J. Biol. Chem. 266, 11192-11198.
6. 2X purinergic receptors in PC12 cells. Anesthesiology 87, 1199-1209.
7. Arias, H. R. (1997). The high-affinity quinacrine binding site is located at a non-annular lipid domain of the nicotinic acetylcholine receptor. Biochim. Biophys. Acta 1347, 9-22.
8. Arias, H. R. (1998). Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor. Biochim. Biophys. Acta Rev. Biomembr. 1376, 173-220.
9. Arias, H. R. (1999a). Role of local anesthetics on both cholinergic and serotonergic ionotropic receptors. Neurosci. Biobehav. Rev. 23, 817-843.
10. Arias, H. R. (1999b). 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor. Arch. Biochem. Biophys 371, 89-97.
11. Arias, H. R. (2000). Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors. Neurochem. Int. 36, 595-645.
12. Arias, H. R. (2001). Thermodynamics of nicotinic receptor interactions. In "Drug-Receptor Thermodynamics: Introduction and Applications" (R. B. Raffa, Ed.), pp. 293-358. John Wley & Sons, New York.
13. Arias, H. R., McCardy, E. A., and Blanton, M. P. (2001b). Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor. Mol. Pharmacol. 59, 1051-1060.
14. Arias, H. R., McCardy, E. M., Gallagher, M. J., and Blanton, M. P. (2001a). Interaction of barbiturate analogs with the Torpedo californica nicotinic acetylcholine receptor ion channel. Mol. Pharmacol. 60, 497-506.
15. Arias, H. R., Machu, T. K., Trudell, J. R., and Blanton, M. P. (2002a). Current perspective of general anesthetic sites of action in ligand-gated ion channel receptors. In "Recent Research Developments in Biophysical Chemistry" (C. A. Condat, and A. Baruzzi, eds.), Transworld Research Network/Research Signpost, India, in press.
16. Arias, H. R., McCardy, E. A., Bayer, E. Z., Gallagher, M. J., and Blanton, M. B. (2002b). Allosterically-linked noncompetitive antagonist binding sites in the resting nicotinic acetyl-choline receptor channel. Arch. Biochem. Biophys. 403, 121-131.
17. Arias, H. R., Trudell, J. R., Bayer, E. Z., Hester, B., McCardy, E. A., and Blanton, M. B. (2002c). Noncompetitive antagonist binding sites in the Torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives. Biochemistry, submitted.
18. Arias, H. R., Valenzuela, C. F., and Johnson, D. A. (1993a). Quinacrine and ethidium bind to different loci on the Torpedo acetylcholine receptor. Biochemistry 32, 6237-6242.
19. Arias, H. R., Valenzuela, C. F., and Johnson, D. A. (1993b). Transverse localization of the quinacrine binding site on the Torpedo acetylcholine receptor. J. Biol. Chem. 268, 6348-6355.
20. Arimura, H., and Ikemoto, Y. (1986). Action of enflurane on cholinergic transmission in identified Aplysia neurons. Br. J. Pharmacol. 89, 573-582.
21. Aronstam, R. S., Narayanan, L., and Wenger, D. A. (1982). Ketamine inhibition of ligand binding to cholinergic receptors and ion channels. Eur. J. Pharmacol. 78, 367-370.
22. Auerbach, A., and Akk, G. (1998). Desensitization of mouse nicotinic acetylcholine receptor channels. A two-gate mechanism. J. Gen. Physiol. 112, 181-197.
23. Barann, M., Wenningmann, I., and Dilger, J. P. (1998). Interactions of general anesthetics within the pore of an ion channel. Toxicol. Lett. 100-101, 155-161.
24. Barbaccia, M. L., Serra, M., Purdy, R. H., and Biggio, G. (2001). Stress and neuroactive steroids. Int. Rev. Neurobiol. 46, 243-272.
25. Baulieu, E. E., Robel, P., and Schumacher, M. (2001). Neurosteroids: Beginning of the story. Int. Rev. Neurobiol. 46, 1-32.
26. Bencherif, M., Eisenhour, C. M., Prince, R. J., Lippiello, P. M., and Lukas, R. J. (1995). The "calcium antagonist" TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, noncompetitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes. J. Pharmacol. Exp. Ther. 275, 1418-1426.
27. Bertaccini, E., and Trudell, J. R. (2001). Molecular modeling of the transmembrane regions of ligand-gated ion channels: Progress and challenges. Int. Rev. Neurobiol. 48, 141-166.
28. Bertaccini, E., and Trudell, J. R. (2002). Predicting the transmembrane secondary structure of ligand-gated ion channels. Prot. Eng. 15, 101-111.
29. Blanton, M. P., and Cohen, J. B. (1992). Mapping the lipid-exposed regions in the Torpedo californica nicotinic acetylcholine receptor. Biochemistry 31, 3738-3750.
30. Blanton, M. P., and Cohen, J. B. (1994). Identifying die lipid-protein interface of the Torpedo nicotinic acetylcholine receptor: Secondary structure implications. Biochemistry 33, 2859-2872.
31. Blanton, M. P., McCardy, E. A., and Gallagher, M. J. (2000). Examining the noncompetitive antagonist-binding site in the ion channel of the nicotinic acetylcholine receptor in the resting state. J. Biol. Chem. 275, 3469-3478.
32. 125I]TIDPC/16. Biochemistry 37, 14545-14555.
33. Blanton, M. P., Xie, Y., Dangott, L. J., and Cohen, J. B. (1999). The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface. Mol. Pharmacol. 55, 269-278.
34. Bouzat, C., and Barrantes, F. J. (1996). Modulation of muscle nicotinic acetylcholine receptors by the glucocorticoid hydrocortisone. Possible allosteric mechanism of channel blockade. J. Biol. Chem. 271, 25835-25841.
35. Brejc, K., van Dijk, W. J., Klaassen, R. V., Schuurmans, M., van der Oost, J., Smit, A. B., and Sixma, T. S. (2001). Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411, 269-276.
36. Bradley, R. J., Sterz, R., and Pepper, K. (1984). The effects of alcohols and diols at the nicotinic acetylcholine receptor of the neuromuscular junction. Brain Res. 295, 101-112.
37. Briggs, C. A., and McKenna, D. G. (1996). Effect of MK-801 at the human α7 nicotinic acetylcholine receptor. Neuropharmacology 35, 407-414.
38. Bufler, J., Pichlmeier, R., Schneck, H. J., Hussman, H., and Franke, C. (1994). Block of nicotinic acetylcholine-activated channels of cultured mouse myotubes by isoflurane. Neurosci. Lett. 168, 135-138.
39. Buisson, B., and Bertrand, D. (1998). Open-channel blockers at the human α4β2 neuronal nicotinic acetylcholine receptor. Mol. Pharmacol. 53, 555-563.
40. Bullock, A. E., Clark, A. L., Grady, S. R., Robinson, S. F., Slobe, B. S., Marks, M. J., and Collins, A. C. (1997). Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J. Neurochem. 68, 2412-2423.
41. Cardoso, R. A., Brozowski, S. J., Chavez-Noriega, L. E., Harpold, M., Valenzuela, F. C., and Harris, R. A. (1999a). Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 289, 774-780.
42. Cardoso, R. A., Yamakura, T., Brozowski, S. J., Chavez-Noriega, L. E., and Harris, R. A. (1999b). Human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes predict afficacy of halogenated compounds that disobey the Meyer-Overton nile. Anesthesiology 91, 1370-1377.
43. Changeux, J.-P., and Edelstein, S. J. (1998). Allosteric receptors after 30 years. Neuron 21, 959-980.
44. Charlesworth, P., and Richards, C. D. (1995). Anaesthetic modulation of nicotinic ion channel kinetics in bovine chromaffin cells. Br. J. Pharmacol. 114, 909-917.
45. Chen, S-W., Rodriguez, L., Davies, M. F., and Loew, G. H. (1996). The hyperphagic effect of 3 α-hydroxylated pregnane steroids in male rats. Pharmacol. Biochem. Behav. 53, 777-782.
46. Chiara, D. C., Kloczewiak, M. A., Addona, G. H., Yu, J.-A., Cohen, J. B., and Miller, K. W. (2001). Site of resting state inhibition of the nicotinic acetylcholine receptor by a hydrophobic inhibitor. Biochemistry 40, 296-304.
47. Coates, K. M., Mather, L. E., Johnson, R., and Flood, P. (2001). Thiopental is a competitive inhibitor at the human α7 nicotinic acetylcholine receptor. Anesth. Analg. 92, 930-933.
48. Colquhoun, D. (1998). Binding, gating, affinity and efficacy: The interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br. J. Pharmacol. 125, 924-947.
49. Connolly, J., Boulter, J., and Heinemann, S. F. (1992). α4-2β2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs. Br. J. Pharmacol. 105, 657-666.
50. Corringer, P.-J., Le Novére, N., and Changeux, J.-P. (2000). Nicotinic receptors at the amino acid level. Annu. Rev. Pharmacol. Toxicol. 40, 431-458.
51. A receptor activity by alphaxalone. Br. J. Pharmacol. 90, 491-500.
52. Covernton, P. J., and Connolly, J. G. (1997). Differential modulation of rat neuronal nicotinic receptor subtypes by acute application of ethanol. Br. J. Pharmacol. 122, 1661-1668.
53. Crews, F. T., Morrow, A. L., Criswell, H., and Breese, G. (1996). Effects of ethanol on ion channels. Int. Rev. Neurobiol. 39, 283-367.
54. Curtis, L., Buisson, B., Bertrand, S., and Bertrand, D. (2002). Potentiation of human α4β2 neuronal nicotinic acetylcholine receptor by estradiol. Mol. Pharmacol. 61, 127-135.
55. Czlonkowska, A. I., Krzascik, P., Sienkiewicz-Jarosz, H., Siemiatkowski, M., Szyndler, J., Maciejak, P., Bidzinski, A., and Plaznik, A. (2001). Tolerance to the anticonvulsant activity of midazolam and allopregnanolone in a model of picrotoxin seizures. Eur. J. Pharmacol. 425, 121-112.
56. Dayton, P. G., Stiller, R. L., Cook, D. R., and Perel, J. M. (1983). The binding of ketamine to plasma proteins: Emphasis on human plasma. Eur. J. Clin. Pharmacol. 24, 825-831.
57. de Armendi, A. J., Tonner, P. H., Bugge, B., and Miller, K. W. (1993). Barbiturate action is dependent of the conformational state of the acetylcholine receptor. Anesthesiology 79, 1033-1041.
58. Dilger, J. P., Boguslavsky, R., Barann, M., Katz, T., and Vidal, A. M. (1997). Mechanisms of barbiturate inhibition of acetylcholine receptor channels. J. Gen. Physiol. 109, 401-414.
59. Dilger, J. P., Brett, R. S., and Lesko, L. A. (1992). Effects of isoflurane on acetylcholine receptor channels. 1. Single-channel currents. Mol. Pharmacol. 41, 127-133.
60. Dilger, J. P., Brett, R. S., and Mody, H. I. (1993). Effects of isoflurane on acetylcholine receptor channels. 2. Currents elicited by rapid perfusion of acetylcholine. Mol. Pharmacol. 44, 1056-1063.
61. Dilger, J. P., Liu, Y., and Vidal, A. M. (1995). Interactions of general anaesthetics with single acetylcholine receptor channels. Eur. J. Anaesthesiol. 12, 31-39.
62. Dilger, J. P., and Vidal, A. M. (1994). Cooperative interactions between general anesthetics and QX-222 within the pore of the acetylcholine receptor ion channel. Mol. Pharmacol. 46, 169-175.
63. Dilger, J. P., Vidal, A. M., Mody, H. I., and Liu, Y. (1994). Evidence for direct actions of general anesthetics on an ion channel protein. A new look at a unified mechanism of action. Anesthesiology 81, 431-442.
64. 3H]quinacrine azide in the active state of the nicotinic acetylcholine receptor. J. Biol. Chem. 265, 11017-11029.
65. Dodson, B. A., Braswell, L. M., and Miller, K. W. (1987). Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes. Mol. Pharmacol. 32, 119-126.
66. Dodson, B. A., Urh, R. R., and Miller, K. W. (1990). Relative potencies for barbiturate binding to the Torpedo acetylcholine receptor. Br. J. Pharmacol. 101, 710-714.
67. Downie, D. L., Franks, N. P., and Lieb, W. R. (2000). Effects of thiopental and its optical isomers on nicotinic acetylcholine receptors. Anesthesiology 93, 774-783.
68. Downie, D. L., Vicente-Agulló, F., Campos-Caro, A., Bushell, T. J., Lieb, W. R., and Franks, N. P. (2002). Determinants of the anesthetic sensitivity of neuronal nicotinic acetylcholine receptors. J. Biol. Chem. 277, 10367-10373.
69. Eaton, M. J., Labarca, C. G., and Eterović, V. A. (2000). M2 mutations of the nicotinic acetylcholine receptor increase the potency of the non-competitive inhibitor phencyclidine. J. Neurosci. Res. 61, 44-51.
70. Eckenhoff, M. F., Chan, K., and Eckenhoff, R. G. (2002). Multiple specific binding targets for inhalated anesthetics in the mammalian brain. J. Pharmacol. Exp. Ther. 300, 172-179.
71. Eckenhoff, R. G. (1996). An inhalational anesthetic binding domain in the nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA 93, 2807-2810.
72. Eger, II, E. I., Koblin, D. D., Harris, R. A., Kendig, J. J., Pohorille, A., Halsey, M. J., and Trudell, J. R. (1997). Hypothesis: Inhaled anesthetics produce immobility and amnesia by different mechanisms at different sites. Anesth. Analg. 84, 915-918.
73. Elgoyhen, A. B., Vetter, D. E., Katz, E., Rothlin, C. V., Heinemann, S. F., and Boulter, J. (2001). α10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc. Natl. Acad. Sci. USA 98, 3501-3506.
74. Ellena, J. F., Blazing, M. A., and McNamee, M. G. (1982). Lipid-protein interactions in reconstituted membranes containing acetylcholine receptor. Biochemistry 22, 5523-5535.
75. Engel, S. R., and Grant, K. A. (2001). Neurosteroids and behavior. Int. Rev. Neurobiol. 46, 321-348.
76. Eterović, V. A., Lu, R., Eakin, A. E., Rodríguez, A. D., and Ferchmin, P. A. (1999). Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ. Cell Mol. Neurobiol. 19, 745-757.
77. Eterović, V. A., Li, L., Ferchmin, P. A., Lee, Y. H., Hann, R. M., Rodríguez, A. D., and McNamee, M. G. (1993). The ion channel of muscle and electric organ acetylcholine receptors: Differing affinities for noncompetitive inhibitors. Cell. Mol. Neurobiol. 13, 111-121.
78. Finn, D. A., Roberts, A. J., and Crabbe, J. C. (1995). Neuroactive steroid sensitivity in withdrawal seizure-prone and -resistant mice. Alcohol. Clin. Exp. Res. 19, 410-415.
79. Flood, P., and Krasowski, M. D. (2000). Intravenous anesthetics differentially modulate ligand-gated ion channels. Anesthesiology 92, 1418-1425.
80. Flood, P., Ramirez-Latorre, J., and Role, L. (1997). α4β2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but α7-type nicotinic acetylcholine receptors are unaffected. Anesthesiology 86, 859-865.
81. Flores, C. M., DeCamp, R. M., Kilo, S., Rogers, S. W., and Hargreaves, K. M. (1996). Neuronal nicotinic receptor expression in sensory neurons of the rat trigeminal ganglion: Demonstration of α3β4, a novel subtype in the mammalian nervous system. J. Neurosci. 16, 7892-7901.
82. Forman, S. A. (1997). Homologous mutations on different subunits cause unequal but additive effects on n-alcohol block in the nicotinic receptor pore. Biophys. J. 72, 2170-2179.
83. Forman, S. A., Miller, K. W., and Yellen, G. (1995). A discrete site for general anesthetics on a postsynaptic receptor. Mol. Pharmacol. 48, 574-581.
84. Forman, S. A., and Zhou, Q. (1999). Novel modulation of a nicotinic receptor channel mutant reveals that the open state is stabilized by ethanol. Mol. Pharmacol. 55, 102-108.
85. Franks, N. P., and Lieb, W. R. (1994). Molecular and cellular mechanisms of general anaesthesia. Nature 367, 607-614.
86. Franks, N. P., and Lieb, W. R. (1998). Which molecular targets are more relevant to general anaesthesia. Toxicol. Lett. 100-101, 1-8.
87. Friederich, P., Dybek, A., and Urban, B. (2000). Stereospecific interaction of ketamine with nicotinic acetylcholine receptors in human sympathetic ganglion-like SH-SY5Y cells. Anesthesiology 93, 818-824.
88. Frye, C. A. (1995). The neurosteroid 3α, 5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 696, 113-120.
89. Frye, C. A. (2001). The role of neurosteroids and nongenomic effects of progestins in the ventral tegmental area in mediating sexual receptivity of rodents. Horm. Behav. 40, 226-233.
90. Frye, C. A., and Duncan, J. E. (1996). Estradiol benzoate potentiates neuroactive steroids' effects on pain sensitivity. Pharmacol. Biochem. Behav. 53, 27-32.
91. Frye, C. A., and Sturgis, J. D. (1995). Neurosteroids affect spatial/reference, working, and long-term memory of female rats. Neurobiol. Learn. Mem. 64, 83-96.
92. 2X purinoceptors in PC12 cells. Anesth. Analg. 88, 174-180.
93. 3H]tetracaine. Mol. Pharmacol. 56, 300-307.
94. 125I]iodophenyl)diazirine and tetracaine, phencyclidine, or histrionicotoxin in the Torbedo species nicotinic acetylcholine receptor ion channel. Mol. Pharmacol. 59, 1514-1522.
95. Garbus, I., Bouzat, C., and Barrantes, F. J. (2001). Steroids differentially inhibit the nicotinic acetylcholine receptor. Neuroreport 12, 227-231.
96. Gillo, B., and Lass, Y. (1984). The mechanism of steroid anaesthetic (alphaxalone) block of acetylcholine-induced ionic currents. Br. J. Pharmacol. 82, 783-789.
97. Godden, E. L., and Dunwiddie, T. V. (2002). Structural requirements of alkanol interaction sites on human α2β4 neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes: Effects of linear and branched-chain alkanols. Alcohol. Clin. Exp. Res. 26, 8-18.
98. Godden, E. L., Harris, R. A., and Dunwiddie, T. V. (2001). Correlation between molecular volume and effects of N-alcohols on human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 296, 716-722.
99. Grewer, C., and Hess, G. P. (1999). On the mechanism of inhibition of the nicotinic acetylcholine receptor by the anticonvulsant MK-801 investigated by laser-pulse photolysis in the microsecond-to-millisecond time region. Biochemistry 38, 7837-7846.
100. Halliwell, R. F., Peters, J. A., and Lambert, J. J. (1989). The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: A voltage clamp study on neuronal cells in culture. Br. J. Pharmacol. 96, 480-494.
101. Heidmann, T., Oswald, R. E., and Changeux, J.-P. (1983). Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments Torpedo marmorata. Biochemistry 22, 3112-3127.
102. Herz, J. M., Johnson, D. A., and Taylor, P. (1989). Distance between the agonist and noncompetitive inhibitor sites on the nicotinic acetylcholine receptor. J. Biol. Chem. 262, 12436-12448.
103. Hess, G. P., Ulrich, H., Breitinger, H. G., Niu, L., Gameiro, A. M., Grewer, C., Srivastava, S., Ippolito, J. E., Lee, S. M., Jayaraman, V., and Coombs, S. E. (2000). Mechanism-based discovery of ligands that counteract inhibition of the nicotinic acetylcholine receptor by cocaine and MK-801. Proc. Natl. Acad. Sci. USA 97, 13895-13900.
104. Hsaio, B., Dweck, D., and Luetje, C. W. (2001). Subunit-dependent modulation of neuronal nicotinic receptors by zinc. J. Neurosci. 21, 1848-1856.
105. Husain, S. S., Forman, S. A., Klockzewiak, M. A., Addona, G. H., Olsen, R. W., Pratt, M. B., Cohen J. D., and Miller, K. W. (1999). Synthesis and properties of 3-(2-hydroxyethyl)-3-n-pentyldiazirine, a photoactivable general anesthetic. J. Med. Chem. 42, 3300-3307.
106. Jacobson, I., Pocock, G., and Richards, C. D. (1991). Effects of pentobarbitone on the properties of nicotinic channels of chromaffin cells. Eur. J. Pharmacol. 202, 331-339.
107. Jones, M. V., and Westbrook, G. L. (1996). The impact of receptor desensitization on fast synaptic transmission. Trends Neurosci. 19, 96-101.
108. Jones, O. T., and McNamee, M. G. (1988). Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry 27, 2364-2374.
109. Kamiya, Y., Andoh, T., Watanabe, I., Higashi, T., and Itoh, H. (2001). Inhibitory effects of barbiturates on nicotinic acetylcholine receptors in rat central nervous system neurons. Anesthesiology 94, 694-704.
110. Kandel, L., Chortkoff, B. S., Sonner, J., Laster, M. J., and Eger, II, E. I. (1996). Nonanesthetics can suppress learning. Anesth. Analg. 82, 321-326.
111. Karlin, A. (2002). Emerging structure of the nicotinic acetylcholine receptor. Nat. Rev. Neurosci. 3, 102-114.
112. Karpen, J. W., Aoshima, H., Abood, L. G., and Hess, G. P. (1982). Cocaine and phencyclidine inhibition of the acetylcholine receptor: Analysis of the mechanisms of action based on measurements of ion flux in the millisecond-to-minute time regime. Proc. Natl. Acad. Sci. USA 79, 2509-2513.
113. Karpen, J. W., and Hess, G. P. (1986). Cocaine, phencyclidine, and procaine inhibition of the acetylcholine receptor: Characterization of the bidning site by stopped-flow measurements of receptor-controlled ion flux in membrane vesicles. Biochemistry 25, 1777-1785.
114. Katz, E. J., Cortes, V. I., Eldefrawi, M. E., and Eldefrawi, A. T. (1997). Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities. Toxicol. Appl. Pharmacol. 146, 227-236.
115. Ke, L., and Lukas, R. J. (1996). Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes. J. Neurochem. 67, 1100-1112.
116. Keyser, K. T., Britto, L. R. G., Schoepfer, R., Whiting, P., Cooper, J., Conroy, W., Borozozowska-Prechtl, A., Karten, H. J., and Lindstrom, J. (1993). Three subtypes of α-bungarotoxin-sensitive nicotinic acetylcholine receptors are expressed in chick retina. J. Neurosci. 13, 442-454.
117. Klink, R., de Kerchove d'Exaerde, A., Zoli, M., and Changeux, J.-P. (2001). Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 21, 1452-1463.
118. Koblin, D. D., Chortkoff, B. S., Laster, M. J., Eger, II, E. I., Halsey, M. J., and Ionescu, P. (1994a). Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. Anesth. Analg. 79, 1043-1048.
119. Koblin, D. D., Chortkoff, B. S., Laster, M. J., Eger, II, E. I., Halsey, M. J., and Ionescu, P. (1994b). Nonanesthetic polyhalogenated alkanes and deviation from the Mayer-Overton hypothesis. Progr. Anesth. Mech. 3, 451-456.
120. Krasowski, M. D., and Harrison, N. L. (1999). General anaesthetic actions on ligand-gated ion channels. Cell. Mol Life Sci. 55, 1278-128.
121. A receptor function. Trends Pharmacol. Sci. 16, 293-303.
122. A receptors. Int. Rev. Neurobiol. 46, 177-205.
123. Léna, C., and Changeux, J.-P. (1998). Allosteric nicotinic receptors, human phatologies. J. Physiol. 92, 63-74.
124. Leonard, S., and Bertrand, D. (2001). Neuronal nicotinic receptors: From structure to function. Nicot. Tobacco Res. 3, 203-223.
125. Liu, Y., Dilger, J. P., and Vidal, A. M. (1994). Effects of alcohol and volatile anesthetics on the activation of nicotinic acetylcholine receptor channels. Mol. Pharmacol. 45, 1235-1241.
126. Lodge, D., Anis, N. A., and Burton, N. R. (1982). Effects of optical isomers of ketamine on excitation of cat and rat spinal neurons by amino acids and acetylcholine. Neurosci. Lett. 29, 281-286.
127. Luntz-Leybman, V., Freund, R. K., and Collins, A. C. (1990). 5α-Pregnan-3α-ol-20-one blocks nicotine-induced seizures and enhances paired-pulse inhibition. Eur. J. Pharmacol. 185, 239-242.
128. Lurtz, M. M., and Pedersen, S. E. (1999). Aminotriarylmethane dyes are high-affinity noncompetitive antagonists of the nicotinic acetylcholine receptor. Mol. Pharmacol. 55, 159-167.
129. Maleque, M. A., Warnick, J. E., and Albuquerque, E. X. (1981). The mechanism and site of action of ketamine on skeletal muscle. J. Pharmacol. Exp. Ther. 219, 638-645.
130. Marubio, L. M., del Mar Arroyo-Jimenez, M., Cordero-Erausquin, M., Léna, C., Le Novére, N., de Kerchove d'Exaerde, A., Huchet, M., Damaj, M. I., and Changeux, J.-P. (1999). Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398, 805-810.
131. Mascia, M. P., Maiya, R., Borghese, C. M., Lobo, I. A., Hara, K., Yamakura, T., Gong, D. H., and Beckstead, M. J. (2001). Does acetaldehyde mediate ethanol action in the central nervous system? Alcohol. Clin. Exp. Res. 25, 1570-1575.
132. Mascia, M. P., Trudell, J. R., and Harris, R. A. (2000). Specific binding sites for alcohol and anesthetics on ligand-gated ion channels. Proc. Natl. Acad. Sci. USA 97, 9305-9310.
133. Mellon, S. H., and Vaudry, H. (2001). Biosynthesis of neurosteroids and regulation of their synthesis. Int. Rev. Neurobiol. 46, 33-78.
134. 7 nicotinic acetylcholine receptor promotes survival of spinal cord motoneurons. FEBS Lett. 411, 32-38.
135. Methot, N., Ritchie, B. D., Blanton, M. P., and Baezinger, J. E. (2001). Structure of the pore-forming trasnmembrane domain of a ligand-gated ion channel. J. Biol. Chem. 276, 23726-23732.
136. McEwen, B. S. (1991). Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12, 141-147.
137. McGehee, D. S., and Role, L. W. (1995). Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57, 521-546.
138. McKenzie, D., Franks, N. P., and Lieb, W. R. (1995). Action of general anaesthetics on a neuronal nicotinic acetylcholine receptor in isolated identified neurons of Lymnaea stagnalis. Br. J. Pharmacol. 115, 275-282.
139. 3H] tetracaine, a nondesensitizing noncompetitive antagonist. Mol. Pharmacol. 56, 290-299.
140. Mok, W. M., Herschkowitz, S., and Krieger, N. R. (1991). In vivo studies identify 5α-pregnan-3α-ol-20-one as an active anesthetic agent. J. Neurochem. 57, 1296-1301.
141. Mori, T., Zhao, X., Zuo, Y., Aistrup, G. L., Nishikawa, K., Marszalec, W., Yeh, J. Z., and Narahashi, T. (2001). Modulation of neuronal nicotinic acetylcholine receptors by halothane in rat cortical neurons. Mol. Pharmacol. 59, 732-743.
142. Mosckovitz, R., Haring, R., Gershoni, J. M., Kloog, Y., and Sokolovsky, M. (1987). Localization of azidophencyclidine-binding site on the nicotinic acetylcholine receptor α-subunit. Biochem. Biophys. Res. Commun. 145, 810-816.
143. Murrell, R. D., Braun, M. S., and Haydon, D. A. (1991). Actions of n-alcohols on nicotinic acetylcholine receptor channels in cultured rat myotubes. J. Physiol. 437, 431-448.
144. Nadeson, R., and Goodchild, C. S. (2001). Antinociceptive properties of neurosteroids III: Experiments with alphadolone given intravenously, intraperitoneally, and intragastrically. Br. J. Anaesth. 86, 704-708.
145. Nagata, K., Aistrup, G. L., Huang, C.-S., Marszalec, W., Song, J.-H., Yeh, J. Z., and Narahashi, T. (1996). Potent modulation of neuronal nicotinic acetylcholine receptor-channel by ethanol. Neurosci. Lett. 217, 186-193.
146. Naguib, M., Flood, P., McArdle, J. J., and Brenner, H. R. (2002). Advances in neurobiology of the neuromuscular junction. Implications for the anesthesiologist. Anesthesiology 96, 202-231.
147. Nakazawa, K., and Ohno, Y. (2001). Modulation by estrogens and xenoestrogens of recombinant human neuronal nicotinic receptors. Eur. J. Pharmacol. 430, 175-183.
148. Narahashi, T., Aistrup, G. L., Marszalec, W., and Nagata, K. (1999). Neuronal nicotinic acetylcholine receptors: A new target site of ethanol. Neurochem. Int. 35, 131-141.
149. Ortells, M. O., and Lunt, G. G. (1995). Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci. 18, 121-127.
150. Pagán, O. R., Eterović, V. A., Garcia, M., Vergne, D., Basilio, C. M., Rodríguez, A. D., and Hann, R. M. (2001). Cembranoid and long-chain alkanol sites on the nicotinic acetylcholine receptor and their allosteric interaction. Biochemistry 40, 11121-11130.
151. Palma, E., Bertrand, S., Binzoni, T., and Bertrand, D. (1996). Neuronal nicotinic α7 receptor expressed in Xenopus oocytes present five putative binding sites for methyllycaconitine. J. Physiol. 491.1, 151-161.
152. Palma, E., Maggi, L., Barabino, B., Eusebi, F., and Ballivet, M. (1999). Nicotinic acetylcholine receptors assembled from the α7 and β3 subunits. J. Biol. Chem. 274, 18335-18340.
153. 2+ on wild and mutant neuronal α7 nicotinic receptors. Proc. Natl. Acad. Sci. USA 95, 10246-10250.
154. Paradiso, K., Sabey, K., Evers, A. S., Zorumski, C. F., Covey, D. F., and Steinbach, J. H. (2000). Steroid inhibition of rat neuronal nicotinic a4β2 receptors expressed in HEK 293 cells. Mol. Pharmacol. 58, 341-351.
155. Paradiso, K., Zhang, J., and Steinbach, J. H. (2001). The C terminus of the human nicotinic a4β2 receptor forms a binding site required for potentiation by an estrogenic steroid. J. Neurosci. 21, 6561-6568.
156. Park-Chung, M., Wu, F. S., Purdy, R. H., Malyev, A. A., Gibbs, T. T., and Farb, D. H. (1997). Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids. Mol. Pharmacol. 52, 1113-1123.
157. Picciotto, M. R., Zoli, M., Lena, C., Bessis, A., Lallemand, Y., LeNovére, N., Vincent, P., Pich, E. M., Brulet, P., and Changeux, J.-P. (1995). Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374, 65-67.
158. Pocock, G., and Richards, C. D. (1988). The action of volatile anesthetics on stimulus-secretion coupling in bovine adrenal chromaffin cells. Br. J. Pharmacol. 95, 209-217.
159. Pratt, M. B., Husain, S. S., Miller, K. W., and Cohen, J. B. (2000). Identification of sites of incorporation in the nicotinic acetylcholine receptor of a photoactivatible general anesthetic. J. Biol. Chem. 275, 29441-29451.
160. 3H]ethidium diazide within the Torpedo nicotinic acetylcholine receptor ion channel. Biochemistry 39, 11452-11462.
161. Pritchett, D. B., Sontheimer, H., Shivers, B. D., Ymer, S., Kettenmann, H., Schofield, P. R., and Seeburg, P. H. (1989). Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature 338, 582-585.
162. Pugh, P. C., and Berg, D. K. (1994). Neuronal acetylcholine receptors that bind alpha-bungarotoxin mediate neurite retraction in a calcium-ependent manner. J. Neurosci. 14, 889-896.
163. Purifoy, J. A., and Holz, R. W. (1984). The effects of ketamine, phencyclidine and lidocaine on catecholamine secretion from cultured bovine adrenal chromaffin cells. Life Sci. 35, 1851-1857.
164. Raines, D. E., Claycomb, R. J., Scheller, M., and Forman, S. A. (2001). Nonhalogenated alkane anesthetics fail to potentiate agonist actions on two ligand-gated ion channels. Anesthesiology 95, 470-477.
165. Raines, D. E., Rankin, S. E., and Miller, K. W. (1995). General anesthetics modify the kinetics of nicotinic acetylcholine receptor desensitization at clinically relevant concentrations. Anesthesiology 82, 276-287.
166. Ramoa, A. S., Alkondon, M., Aracava, Y., Irons, J., Lunt, G. G., Deshpande, S. S., Wonnacott, S., Aronstam, R. S., and Alburquerque, E. X. (1990). The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J. Pharmacol. Exp. Ther. 254, 71-82.
167. Role, L. W., and Berg, D. K. (1996). Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16, 1077-1085.
168. Roth, S. H., Forman, S. A., Braswell, L. M., and Miller, K. W. (1989). Actions of pentobarbital enantiomers on nicotinic cholinergic receptors. Mol. Pharmacol. 36, 874-880.
169. Ryan, S. E., Blanton, M. P., and Baenziger, J. E. (2001). A conformational intermediate between the resting and desensitized states of the nicotinic acetylcholine receptor. J. Biol. Chem. 276, 4796-4803.
170. Ryder, S., Way, W. L., and Trevor, A. J. (1978). Comparative pharmacology of the optical isomers of ketamine in mice. Eur. J. Pharmacol. 49, 15-23.
171. Sabey, K., Paradiso, K., Zhang, J., and Steinbach, J. H. (1999). Ligand binding and activation of rat nicotinic α4β2 receptors stably expressed in HEK293 cells. Mol. Pharmacol. 55, 58-66.
172. Sasaki, T., Andoh, T., Watanabe, I., Kamiya, Y., Itoh, H., Higashi, T., and Matsuura, T. (2000). Nonstereoselective inhibition of neuronal nicotinic acetylcholine receptors by ketamine isomers. Anesth. Analg. 91, 741-748.
173. Scheller, M., Bufler, J., Hertle, I., Schneck, H. J., Franke, C., and Kochs, E. (1996). Ketamine blocks currents through mammalian nicotinic acetylcholine receptor channels by interaction with both the open and the closed state. Anesth. Analg. 83, 830-836.
174. Scheller, M., Buffler, J., Schneck, H., Kochs, E., and Franke, C. (1997). Isoflurane and sevoflurane interact with the nicotinic acetylcholine receptor channels in micromolar concentrations. Anesthesiology 86, 118-127.
175. Seto, T., and Firestone, L. L. (2000). Effects of normal alcohols and isofluorane on lipid head-group dynamics in nicotinic acetylcholine receptor-rich lipid vesicles. Biochim. Biophys. Acta 1509, 111-122.
176. Sonner, J., Li, J., and Eger, II, E. I. (1998). Desflurane and nitrous oxide, but not non-immobilizers, affect nociceptive responses. Anesth. Analg. 86, 629-634.
177. Sumikawa, K., Matsumoto, T., Amenomori, Y., Hirano, H., and Amakata, Y. (1983). Selective action of intravenous anesthetics on nicotinic- and muscarinic-receptor-mediated responses of the dog adrenal medulla. Anesthesiology 59, 412-416.
178. 3 receptor. J. Pharmacol. Exp. Ther. 290, 129-135.
179. Svensson, A. L., and Nordberg, A. (1999). β-Estradiol attenuate amyloid β-peptide toxicity via nicotinic receptors. Neuroreport 26, 3485-3489.
180. Swope, S. L., Moss, S. J., Raymond, L. A., and Huganir, R. L. (1999). Regulation of ligand-gated ion channels by protein phosphorylation. Adv. Second Messenger Phosphoprot. Res. 33, 49-78.
181. Tamamizu, S., Todd, A. P., and McNamee, M. G. (1995). Mutations in the M1 region of the nicotinic acetylcholine receptor alter the sensitivity to inhibition by quinacrine. Cell. Mol. Neurobiol. 15, 427-438.
182. Tassonyi, E., Charpantier, E., Muller, D., Dumont, L., and Bertrand, D. (2002). The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia. Brain Res. Bull. 57, 133-150.
183. A receptor: Dependence on receptor subunit combination. Br. J. Pharmacol. 117, 521-527.
184. Tonner, P. H., and Miller, K. W. (1995). Molecular sites of general anaesthetic action on acetylcholine receptors. Eur. J. Anaesthesiol. 12, 21-30.
185. Trudell, J. R., Hubbell, W. L., and Cohen, E. N. (1973). The effect of two inhalation anesthetics on the order of spin-labeled phospholipid vesicles. Biochim. Biophys. Acta 291, 321-327.
186. Trudell, J. R. (1977). A unitary theory of anesthesia based on lateral phase separations in nerve membranes. Anesthesiology 46, 5-10.
187. Uki, M., Nabekura, J., and Akaike, N. (1999). Supression of the nicotinic acetylcholine response in rat superior cervical ganglion neurons by steroids. J. Neurochem. 72, 808-814.
188. Unwin, N. (2000). The Croonian Lecture 2000. Nicotinic acetylcholine receptor and the structural basis of fast synaptic transmission. Phil. Trans. R. Soc. Lond. B 355, 1813-1829.
189. Valera, S., Ballivet, M., and Bertrand, D. (1992). Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA 89, 9949-9953.
190. Violet, J. M., Downie, D. L., Nakisa, R. C., Lieb, W. R., and Franks, N. P. (1997). Differential sensitivities of mammalian neuronal and muscle nicotinic acetylcholine receptors to general anesthetics. Anesthesiology 86, 866-874.
191. 3H] phencyclidine binding to electric organ membrane. J. Pharmacol. Exp. Ther. 221, 570-576.
192. Wachtel, R. E. (1995). Relative potenties of volatile anesthetics in altering the kinetics of ion channels in BC3H1 cells. J. Pharmacol. Exp. Ther. 274, 1355-1361.
193. Wang, F., Gerzanich, V., Wells, G. B., Anand, R., Peng, X., Keyser, K., and Lindstrom, J. (1996). Assembly of human neuronal nicotinic receptor α5 subunits with α3, β2, and β4 subunits. J. Biol. Chem. 271, 17656-17665.
194. Watanabe, I., Andoh, T., Furuya, R., Sasaki, T., Kamiya, Y., and Itoh, H. (1999). Depressant and convulsant barbiturates both inhibit neuronal nicotinic acetylcholine receptors. Anesth. Analg. 88, 1406-1411.
195. Wenningmann, I., Barann, M., Vidal, A. M., and Dilger, J. P. (2001). The effects of isoflurane on acetylcholine receptor channels: 3. Effects of conservative polar-to-nonpolar mutations within the channel pore. Mol. Pharmacol. 60, 584-594.
196. Weiland, S., Belluzzi, J. D., Stein, L., and Lan, N. C. (1995). Comparative behavioral characterization of the neuroactive steroids 3α-OH, 5α-pregnan-20-one and 3α-OH, 5β-pregnan-20-one in rodents. Psychopharmacology 118, 65-71.
197. White, B. H., and Cohen, J. B. (1992). Agonist-induced changes in the structure of the acetylcholine receptor M2 region revealed by photoincorporation of an uncharged nicotinic noncompetitive antagonist. J. Biol. Chem. 267, 15770-15783.
198. 125I]iodophenyl) diazirine is a novel noncompetitive antagonist of the nicotinic acetylcholine receptor. J. Biol. Chem. 266, 21595-21607.
199. White, P. F., Schuttler, J., Shafer, A., Stanski, D. R., Horai, Y., and Trevor, A. J. (1985). Comparative pharmacology of the ketamine isomers. Studies in volunteers. Br. J. Anaesth. 57, 197-203.
200. Wick, M. J., Mihic, S. J., Ueno, S., Mascia, M. P., Trudell, J. R., Brozowski, S. J., Ye, Q., Harrison, N. L., and Harris, R. A. (1998). Mutations of GABA and glycine receptors change alcohol cutoff: Evidence for an alcohol receptor? Proc. Natl. Acad. Sci. USA 95, 6504-6509.
201. Wilson, G. G., and Karlin, A. (1998). The location of the gate in the acetylcholine receptor channel. Neuron 20, 1269-1281.
202. Wilson, G. G., and Karlin, A. (2001). Acetylcholine receptor channel structure in the resting, open, and desensitized states probed with the substituted-cysteine-accessibility method. Proc. Natl. Acad. Sci. USA 98, 1241-1248.
203. Wonnacott, S. (1997). Presynaptic nicotinic ACh receptors. Trends Neurosci. 20, 92-98.
204. Wood, S. C., Forman, S. A., and Miller, K. W. (1991). Short chain and long chain alkanols have different sites of action on nicotinic acetylcholine receptor channels from Torpedo. Mol. Pharmacol. 39, 332-338.
205. Wood, S. C., Hill, W. A., and Miller, K. W. (1993). Cycloalkanemethanols discriminate between volume- and length-ependent loss of activity of alkanols at the Torpedo nicotinic acetylcholine receptor. Mol. Pharmacol. 44, 1219-1226.
206. Wood, S. C., Tonner, P. H., de Armendi, A. J., Bugge, B., and Miller, K. W. (1995). Channel inhibition by alkanols occurs at a binding site on the nicotinic acetylcholine receptor. Mol. Pharmacol. 47, 121-130.
207. Wu, G., Tonner, P. H., and Miller, K. W. (1994). Ethanol stabilizes the open channel state of the Torpedo nicotinic acetylcholine receptor. Mol. Pharmacol. 45, 102-108.
208. Xu, W., Gelber, S., Orr-Urtreger, A., Armstrong, D., Lewis, R. A., Ou, C. N., Patrick, J., Role, L., De Biasi, M., and Beaudet, A. L. (1999a). Megacystis, mydriasis, and ion channel defect in mice lacking the α3 neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA 96, 5746-5751.
209. Xu, W., Orr-Urtreger, A., Nigro, F., Gelber, S., Sutcliffe, Armstrong, D., Patrick, J. W., Role, L. W., Beaudet, A. L., and De Biasi, M. (1999b). Multiorgan autonomic dysfunction in mice lacking the β2 and the β4 subunits of neuronal nicotinic acetylcholine receptors. J. Neurosci. 19, 9298-9305.
210. Xu, Y., Seto, T., Tang, P., and Firestone, L. O. (2000). NMR study of volatile anesthetic binding to nicotinic acetylcholine receptors. Biophys. J. 78, 746-751.
211. Yamakura, T., Bertaccini, E., Trudell, J. R., and Harris, R. A. (2001). Anesthetics and ion channels: Molecular models and sites of action. Annu. Rev. Pharmacol. Toxicol. 41, 23-51.
212. Yamakura, T., Borghese, C., and Harris, A. (2000a). A transmembrane site determines sensitivity of neuronal nicotinic acetylchopline receptors to general anesthetics. J. Biol. Chem. 275, 40879-40886.
213. Yamakura, T., Chavez-Noriega, L. E., and Harris, R. A. (2000b). Subunit-ependent inhibiton of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics and dizocilpine. Anesthesiology 92, 1144-1153.
214. Yamakura, T., and Harris, R. A. (2000). Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Anesthesiology 93, 1095-1101.
215. Yashima, N., Wada, A., and Izumi, F. (1986). Halothane inhibits the cholinergic-receptor-mediated influx of calcium in primary culture of bovine adrenal medulla cells. Anesthesiology 64, 466-472.
216. Yost, C. S., and Dodson, B. A. (1993). Inhibition of the nicotinic acetylcholine receptor by barbiturates and by procaine. Cell. Mol. Neurobiol. 13, 159-172.
217. Yu, C. R., and Role, L. W. (1998). Functional contribution of the α5 subunit to neuronal nicotinic channels expressed by chick sympathetic ganglion neurones. J. Physiol. 509, 667-681.
218. Yu, D., Zhang, L., Eiselé, J. L., Bertrand, D., and Changeux, J.-P. (1996). Ethanol inhibition of nicotinic acetylcholine type α7 receptors involves the amino-terminal domain of the receptor. Mol. Pharmacol. 50, 1010-1016.
219. Zaman, S. H., Shingai, R., Harvey, R. J., Darlison, M. G., and Barnard, E. A. (1992). Effects of subunit types of the recombinant GABAA receptor on the response to a neurosteroid. Eur. J. Pharmacol. 225, 321-330.
220. 3 receptors expressed in Xenopus oocytes. Br. J. Pharmacol. 120, 353-355.
221. Zhou, Q. L., Zhou, Q., and Forman, S. A. (2000). The n-alcohol site in the nicotinic receptor pore is a hydrophobic patch. Biochemistry 39, 14920-14926.
222. Zuo, Y., Aistrup, G. L., Marszalec, W., Gillespie, A., Chavez-Noriega, L. E., Yeh, J. Z., and Narahashi, T. (2001). Dual action of n-alcohols on neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 60, 700-711.
223. 2+. Eur. J. Pharmacol. 291, 399-406.